Document is current
Any future updates will be listed below
-
Authors
Leening, Maarten J.G. https://orcid.org/0000-0002-4143-4839
Boersma, Eric
- License Information
-
More Information
Article History
Received: 9 April 2024
Accepted: 15 April 2024
First Online: 11 May 2024
Declarations
:
: MJGL reports receiving speaker fees from Sanofi, Novartis, and Daiichi Sankyo; and served on advisory boards for Boehringer Ingelheim; and Sanofi; all unrelated to the topic of this manuscript. EB is a member of the Dutch Medicines Evaluation Board (CBG); opinions expressed in this commentary are his own and do not necessarily those of the CBG.
